Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
about
Altered expression of a putative progenitor cell marker DCAMKL1 in the rat gastric mucosa in regeneration, metaplasia and dysplasia.Intestinal stem cells and their roles during mucosal injury and repair.Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells.Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice.A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patientsExpansion of intestinal epithelial stem cells during murine development.Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis.Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor developmentSustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.Targeting breast cancer stem cells.Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibitionDistinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium.Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.Intestinal stem cells remain viable after prolonged tissue storage.Cell lineage identification and stem cell culture in a porcine model for the study of intestinal epithelial regeneration.Gut microbiome and anticancer immune response: really hot Sh*t!A multicellular approach forms a significant amount of tissue-engineered small intestine in the mouse.Side populations from cervical-cancer-derived cell lines have stem-cell-like properties.Phosphorylation of Smad2/3 at specific linker threonine indicates slow-cycling intestinal stem-like cells before reentry to cell cycle.Expansion of Paneth cell population in response to enteric Salmonella enterica serovar Typhimurium infectionPorcine models of digestive disease: the future of large animal translational research.Epidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition.Tissue underlying the intestinal epithelium elicits proliferation of intestinal stem cells following cytotoxic damage.Loss of ADAM17-Mediated Tumor Necrosis Factor Alpha Signaling in Intestinal Cells Attenuates Mucosal Atrophy in a Mouse Model of Parenteral NutritionAlteration of colonic stem cell gene signatures during the regenerative response to injuryDepletion of enteric bacteria diminishes leukocyte infiltration following doxorubicin-induced small intestinal damage in miceToll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosisβ-Arrestin1 inhibits chemotherapy-induced intestinal stem cell apoptosis and mucositis.Paneth cells expand from newly created and preexisting cells during repair after doxorubicin-induced damage.Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis.Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis.Side population sorting separates subfractions of cycling and non-cycling intestinal stem cellsQuiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance.Intestinal stem cell injury and protection during cancer therapyNanomaterials for targeted drug delivery to cancer stem cells.Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research.Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells.Slow-cycling therapy-resistant cancer cellsTherapeutic targeting of cancer stem cells.CD44 and TLR4 mediate hyaluronic acid regulation of Lgr5+ stem cell proliferation, crypt fission, and intestinal growth in postnatal and adult mice.
P2860
Q33611061-50D6B793-607E-4E42-AA7D-6CC5E6D91523Q33692786-5F1687AF-74AF-48B0-8BD7-84FED83B75FEQ33779894-4B3D0DD7-B366-4D29-8E64-3CECD181FB0FQ34010008-5504C288-3E0A-443E-B114-BD959EE56175Q34041858-ACE0C76F-22B4-4F0C-B3AB-B95CCCE24672Q34079249-640FBF31-BEEE-4EEA-9966-8CCECC05E2E2Q34129345-32332948-7A50-49A2-B64F-FA0A9F2A3046Q34205259-BFA17010-9981-4A67-9F65-DED4569576F9Q34425937-B61236AF-52D7-4671-8A4A-C0E998AB571AQ34505105-11709681-3B41-43FF-9F45-6A6BEBE9F5E5Q34522818-26C5DF06-FCAE-4FA7-9954-B2E344D41488Q34637873-64151547-2AF2-4A4B-9CF4-C597026EEFA0Q34698758-553266DB-343B-4FD0-961C-6DFE351113E2Q34791082-257B9CA8-D11A-46A2-8331-EC54EB86CE95Q34805506-19015D8A-D28F-40C2-8261-EF4325255A8EQ34924272-C439B364-0210-4614-B248-F4AFF379D81BQ35055508-427341FF-907E-48C1-B630-0026B6BD2820Q35085092-2D205C8E-6952-4A84-A324-42A21A242B61Q35237708-57B35E90-6B31-4E82-882F-D7C72E18EB8BQ35665333-4B6435AA-E5C2-4BF2-BC8B-300730E1D6E7Q35691021-3971F71C-2E67-494D-B9C6-DE06E37BF0D6Q35925157-68B54FC2-A02D-4346-88F3-DFB10F9C891BQ35931542-DD9D25A2-6BCA-4011-9DC5-3853E917CC24Q36109388-6BCE25E7-C4C6-46F0-B018-4F3237815411Q36161952-EE8F1BBD-9A15-4486-824E-2FAB8FA251B1Q36296826-1848E0D5-5469-4816-9F3F-0F44E7BB8BFAQ36347820-56230EF0-F3D4-4F58-8959-93648A5801C9Q37030328-EF942106-CD79-4AC4-886C-8FC662755408Q37051514-75D59C61-7730-43DD-9884-542A3F1E5D1AQ37303696-8CB0B717-F607-4115-AC12-A9BC5DD00067Q37607488-F47DCAAE-0F81-4A63-944F-4C25450D032EQ37633546-36599A04-CB1F-4C51-8747-5A502D085F2CQ37799253-DCDAC85F-3F46-4483-B9E0-B9A58BABF68DQ38200606-6D804927-7502-46C3-BCD5-F606F30A5DE5Q38201740-C80692EA-8716-4B53-9942-8FA9F1030A17Q38270128-3961D1F9-F8AC-42F6-91FB-5B5ADCC9E90EQ38957705-015FFEB6-2EEC-44F8-B70F-64FFB1BA9BCAQ39463009-E80B8645-B79B-45CD-92F9-CE029094D631Q42175003-F6E78B48-545C-4853-B01E-2091DF218AD8Q42181705-0FA6AFEE-3222-401B-9B23-AC85B3FF1388
P2860
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
@en
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
@nl
type
label
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
@en
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
@nl
prefLabel
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
@en
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
@nl
P2093
P2860
P356
P1476
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
@en
P2093
Aaron P Garrison
Ajay S Gulati
Christopher M Dekaney
Michael A Helmrath
Susan J Henning
P2860
P304
P356
10.1152/AJPGI.90446.2008
P577
2009-07-09T00:00:00Z